AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06614413 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Neurodevelopment and behaviour assesment 2 years old
Description: Mothers: Monthly visits guided or not by nutritionist (intervention vs control group) will consist in food questionnaires and 3-day food diary collection during pregnancy. Every three months during lactation. Children: From one year of age onwards, the KIDMED questionnaire will be administered quarterly Neurodevelopment and behavior assessment 18-24 months of age
Study NCT06614413 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Neurodevelopment and behaviour assesment 2 years old
Description: Mothers: Monthly visits guided or not by nutritionist (intervention vs control group) will consist in food questionnaires and 3-day food diary collection during pregnancy. Every three months during lactation. Children: From one year of age onwards, the KIDMED questionnaire will be administered quarterly Neurodevelopment and behavior assessment 18-24 months of age
Study NCT06614621 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adebrelimab +Etoposide+Platinum-based drugs
Description: Adebrelimab：20mg/kg或1200mg ivgtt ，d1 ，Q3W Etoposide injection (E): 100mg/m2, ivgtt, d1,d2,d3,Q3W Platinum-based drugs：75mg/m2， ivgtt， d1,d2,d3,Q3W
Study NCT06614621 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Maintenance treatment period:
Description: Adebrelimab：20mg/kg或1200mg，IV, Q3W； Apatinib Mesylate Tablets：250mg，P.O，qod
Study NCT06614530 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Chilipad Docker Pro
Description: The Chilipad Dock Pro is an advanced sleep system designed to optimize sleep by dynamically adjusting the bed\&#39;s surface temperature. It consists of a mesh mattress pad and a Dock Pro control unit that circulates water through the pad, allowing users to customize the temperature between 55°F and 115°F. The system offers both single and dual control, making it ideal for individual or shared use. Equipped with AI-driven features, the Dock Pro can monitor sleep patterns and environmental factors to make real-time adjustments, ensuring optimal sleep conditions throughout the night. This intelligent temperature management system is enhanced when paired with the optional Sleepme Tracker, creating a personalized sleep experience.
Study NCT06527768 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Theory-based health behaviour change interventio
Description: The online individual education sessions are related to MetS, CKD, healthy dietary and PA, displayed in the form of texts and pictures, and online instant conversations via WeChat. The online group music-paced brisk walking training includes a 5-minute warm-up, 30-minute music-paced brisk walking, and 5-minute stretching exercises to promote cool-down. The group discussion is related to current health status, recommended dietary regimens, and exercise and personal goals. The telephone follow-up after the group discussion is to reinforce the predetermined goals and the practice of healthy dietary and music-paced brisk walking, and to provide opportunities for answering any questions related to the practice of healthy dietary and music-paced brisk walking. All the education session contents are based on a well-structured health handbook. The self-music-paced brisk walking is required to be performed for 30 minutes/day, 5 days/week.
Study NCT06668740 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: The use of Virtual Reality Glasses in Elderly
Description: The group first completed a pretest, after which they watched 360-degree VR videos, such as nature walks and trips, for 10 minutes once a week over four weeks. Following this, a posttest was conducted. The outcomes will be used to measure changes in Quality of Life.
Study NCT05706025 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: EnteroTracker
Description: The EnteroTracker® is a capsule device that includes an absorbent string.
Study NCT06615115 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: All participants will perform a total body stretching exercise for 10 minutes, followed by 10 minutes of obstacle course navigation, 10 minutes of balance training (including tandem walking, balance board exercises, single-leg balance, and two-legged reaching exercises), and will conclude with 10 minutes of strength training exercises.
Study NCT06614569 — intervention group
Intervention type: DRUG
Intervention: AXO-AAV-GM2
Description: Participants who received AXO-AAV-GM2 will be tracked in long term follow up
Study NCT06042725 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo optional collection of blood samples
Study NCT06042725 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Marrow Aspiration
Description: Undergo bone marrow aspiration
Study NCT06042725 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Marrow Biopsy
Description: Undergo bone marrow biopsy
Study NCT06042725 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Chest Radiography
Description: Undergo chest x-ray
Study NCT06042725 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo PET/CT
Study NCT06042725 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Daratumumab
Description: Given SC
Study NCT06042725 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Given PO
Study NCT06042725 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenalidomide
Description: Given PO
Study NCT06042725 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Low Dose Computed Tomography of the Whole Body
Description: Undergo WBLDCT
Study NCT06042725 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI
Study NCT06042725 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: Undergo PET/CT
Study NCT06042725 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Venetoclax
Description: Given PO
Study NCT06042725 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: X-Ray Imaging
Description: Undergo x-rays
Study NCT06042725 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT05870930 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Carob beverage
Description: Volunteers will consume 2 tablespoons of carob powder in 200mL drinking water.
Study NCT06693999 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Google-Pixel Watch 3
Description: The participant will wear Google-Pixel Watch 3 for at least 10 hours during the 3-month intervention and will receive goal reminders and motivational and coping messages through those watches. At baseline and after 3-months intervention, demographics (standard questionnaire pertaining to subjects' age, sex, race, education and income), technology literacy (eHealth Literacy Scale pertaining to subjects' ability to perform a number of tasks such as turning on the device, using internet and communication), and wearables affinity (pertains to how the subject currently uses wearable in their daily living tasks) will be measured.
Study NCT06693999 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Exercise prompts
Description: The participants will receive goal reminders.
Study NCT06690398 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lumateperone high dose
Description: Lumateperone administered orally once daily
Study NCT06690398 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lumateperone low dose
Description: Lumateperone administered orally once daily
Study NCT06690398 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching Placebo administered orally once daily
Study NCT06697392 — intervention group
Intervention type: OTHER
Intervention: ultrasound examination
Description: The investigators intend to perform ultrasound examinations for the participants with CTS.
Study NCT05592613 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Next-generation Reader and ID-Cap System
Description: The digital pill system (DPS) is comprised of an ingestible radiofrequency emitter, integrated into a standard gelatin capsule, which then over-encapsulates the study medication (PrEP or ART). On ingestion, the radiofrequency emitter is activated by chloride ions in the stomach, projecting a signal approximately three feet off the body. This radio signal is acquired by a wearable device (Reader) which stores and forwards data to a smartphone, enabling on-demand access to adherence data. The next-generation Reader is a wrist-borne device.
Study NCT05592613 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Truvada for pre-exposure prophylaxis (PrEP)
Description: Participants will ingest one Truvada digital pill as PrEP per day, for 30 days total.
Study NCT05592613 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Biktarvy for antiretroviral therapy (ART)
Description: Participants will ingest one Biktarvy digital pill as ART per day, for 30 days total.
Study NCT06711679 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Low-dose ropivacaine
Description: 0.5 ml/Kg ropivacaine
Study NCT06711679 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Medium-dose of ropivacaine
Description: 1ml/Kg ropivacaine
Study NCT06711679 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: High-dose ropivacaine
Description: 1.5 ml/Kg ropivacaine
Study NCT06711380 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Peer Ambassador
Description: Patient mentor (patient with history of gynecologic cancer who has experience with clinical trials) one on one discussion with patient mentee (patient receiving standard of care treatment for gynecologic cancers).
Study NCT06708325 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Resistance Training Program
Description: The 12-week resistance training program consisted of three supervised sessions per week, each lasting approximately 55-60 minutes. Sessions were structured as follows: 5-7 minute dynamic warm-up, 35-40 minutes of resistance training, and 4-5 minutes of stretching for active recovery.Participants were paired based on similar strength fitness levels and progressed according to the principle of periodized progressive overload. Training was delivered using a circuit protocol with 2-3 sets per exercise. The initial 4-week phase included 2 sets per exercise, with 8-20 repetitions and 1-2 minutes rest between sets. .The program incorporated functional exercises targeting the lower extremities, core, and upper extremities, utilizing equipment such as resistance bands, medicine balls, jump ropes, dumbbells, bars, and stability balls. Participants performed exercises in a circuit sequence, with the intensity, number of sets, and repetitions
Study NCT05765617 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Calcitriol
Description: The treatment group received calcitriol 2x400 iu per day for five days. Calcitriol uses Oscal, obtained from Kalbe Pharma
Study NCT05765617 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo give 2x1 per day for five day
Study NCT06711653 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Vestibular evoke myogenic potential
Description: routine Vestibular test
Study NCT06697457 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Craniocervical Flexion Exercise Group
Description: The patient will first be taught to contract the deep cervical flexors. Patients will be placed in a supine position (without a pillow) to ensure a neutral neck position. Patients will be asked to perform slow, controlled head and upper cervical flexion by bringing the chin closer to the chest (yes movement). The stabilizer will be inflated to 20 mmHg. Gradual training will be given to increase the pressure value by 2 mmHg between 20 and 30 mmHg. Each pressure value (22, 24, 26, 28 mmHg) will be held for 10 seconds and repeated 10 times. The exercise will be performed with 10 repetitions, 10 seconds of contraction and 5 seconds of relaxation. Exercise training will begin with 20 mmHg and once the patient can hold it for 10 seconds with 10 repetitions, the next level on the pressure stabilizer will be moved on.Treatments will be performed 3 days a week for 8 weeks.
Study NCT06697457 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Treatment Group
Description: TENS will be applied with a TENS device at an intensity of 10-30 mA and a frequency of 80 Hz for 20 minutes. A pair of surface electrodes will be placed on the painful area of the neck. The intensity of TENS will be adjusted according to the patient's sensory thresholds so that the patient is not disturbed by a numb feeling. After TENS, continuous ultrasound will be applied to the cervical region to produce thermal effects. The intensity will be 1.5 W/cm² and the duration will be 5 minutes. Hotpack will be applied to the trapezius muscle for 10 minutes. Chin tuck exercise will be applied to the cervical region.Treatments will be performed 3 days a week for 8 weeks.
Study NCT06697457 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Dynamic Isometric Exercise Group
Description: The exercises will be performed by the patient with an elastic band. The progression of the exercises will be performed using different colors of Thera-bands with different resistances. It will start with the red Thera-band with the lowest resistance and then move on to the green and then blue Thera-bands with increasing resistance. Cervical isometric exercises will be performed with elastic resistance bands, maintaining the chin tuck position, forward, backward, crosswise, right and left. There will be 10 repetitions for 10 seconds for each. Progression in Therabands will be according to the patient. When the patient does 10 repetitions for 10 seconds, the next Theraband will be used.Treatments will be performed 3 days a week for 8 weeks.
Study NCT06697457 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Static Isometric Exercise Group
Description: The patient will perform isometric exercises with maximal effort against neck flexion, extension, lateral flexion and rotation with his/her hand in a sitting position. Each exercise will be performed for 10 seconds, with 15-second breaks in between, for 10 repetitions. Each patient will start with submaximal resistance to help them adapt to isometric exercises, and then progress will be checked until the patient reaches the maximum resistance that can be tolerated by each session. It will consist of cervical flexion, cervical extension, right lateral flexion, left lateral flexion, right rotation, left rotation exercises. Progress in the exercises will be according to the Rating of Perceived Exertion Borg (RPE) Scale according to the weeks.Treatments will be performed 3 days a week for 8 weeks.
Study NCT06713018 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Three cannulated compression screws by navigation system
Description: Patients with femoral neck fractures treated with three cannulated compression screws assisted by a navigation system
Study NCT06713018 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Traditional three cannulated compression screws
Description: Patients with femoral neck fractures treated with traditional three cannulated compression screws
Study NCT06705491 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: TIPPI-R
Description: The TIPPI-R intervention protocol consists of a one session, during which time the interventionist offers psychoeducation related to the following content areas: procedural pain related to oncology treatment, factors that may affect the perception of pain, evidenced-based tools for assessing and monitoring pain, cognitive and behavioral pain management interventions, and resources to facilitate family to advocacy for pain management in a medical setting. During this session, the interventionist discusses opportunities for families to utilize skills throughout treatment, and addresses family questions as needed. A follow-up session 4 weeks after the initial intervention session will assess family knowledge and skills and offer a referral for a mental health provider, if further pain management support is needed. TIPPI-R is designed to be delivered by a psychologist, psychology trainee, or social worker working in the oncology context.
Study NCT06711289 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Carotid ultrasound measurement
Description: Pulsed-wave Doppler acquisition of the carotid artery. One acquisition will be made with the slow-speed setting (33 mm/s) and one with the medium-speed setting (66 mm/s).
Study NCT06711289 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Vital sign measurement
Description: Measurement of noninvasive blood pressure, at different time points before and after the induction of spinal anesthesia.
Study NCT06711289 — intervention group
Intervention type: DRUG
Intervention: Spinal anesthesia
Description: Following the standard of care, the patients received spinal anesthesia. The type and dosage of the local anesthetic were at the discretion of the treating anesthesiologist.
Study NCT05226741 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Head protection device
Description: The participants are fitted with a form of head protection over the craniectomy and provide feedback on design, use, and comfort
Study NCT05376943 — intervention group
Intervention type: DRUG
Intervention: Direct Acting Antivirals
Description: Our observational study will assess the exposure to direct acting antivirals - the specific drugs, dose, duration of the therapy and the effect of the treatment.
Study NCT06024031 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: N-acetyl-L-cysteine
Description: N-acetyl-L-cysteine (Yiweishi) capsules (Guangdong Renrenkang Pharmaceutical Industry) will be given orally 400mg three times a day from day 1 to day 28 after chemotherapy. In case of drug allergy such as nausea, vomiting, rash and bronchospasm, and disease relapse, to discontinue the drug immediately.
Study NCT06349096 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Alma Harmony
Description: The ClearLift is a class IIb medical device, High Power Q-switched (QS) 1064nm Nd:YAG laser module in the Harmony system. It has a targeted laser module for the non-invasive removal of various colored tattoos, as well as deep and superficial benign pigmented lesions, wrinkles, fine lines, and skin tightening.
Study NCT06015672 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Transcranial Magnetic Stimulation (TMS)
Description: Participants will experience three accelerated transcranial magnetic stimulation (TMS) sessions, with 12 week (three-months) gap between each session.
Study NCT06015672 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Transcranial Magnetic Stimulation (TMS)
Description: Participants will experience three accelerated transcranial magnetic stimulation (TMS) sessions, with 12 week (three-months) gap between each session.
Study NCT05856058 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR0302
Description: SHR0302 oral solution 1 time, SHR0302 tablets 1 time
Study NCT04939558 — intervention group
Intervention type: DEVICE
Intervention: N-Tidal C handset
Description: Participants are to use the 'N-Tidal C' handset every day for 14 days. This will ideally be two times a day (once in the morning and once in the evening, before using any regular inhalers). Each breath record requires the participant to breathe through the mouthpiece for 75 seconds in a relaxed manner.
Study NCT05316688 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Near Infrared Imaging
Description: Undergo NIR imaging
Study NCT05316688 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Therapeutic Conventional Surgery
Description: Undergo surgery
Study NCT05316688 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tozuleristide
Description: Given IV
Study NCT06039410 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ISO-101
Description: ISO-101 is an experimental wearable class 1 medical device which when used is able to raise the blood pressure upon standing via controlled isometric muscular contractions
Study NCT05850312 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Gamified Digital Intervention - Feasibility Analysis on MoM
Description: In first round we aim to clinically analyze the game Militant of the Maze (MoM) as a vehicle for Exposure Theory, including, play, observation, and feedback from five clinicians.
Study NCT05850312 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Gamified Digital Intervention
Description: In the first phase of round 2 of the study, 5 clinicians will play the game to evaluate the revised game MoMG. In the next phase, 5 carefully-selected non-clinician participants will play the game. under real-time observation of clinicians, to ensure that subjects experience no harm, and that the gameplay is interesting and enjoyable.
Study NCT06713291 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Sliding compression locking plate
Description: The patients with femoral neck fracture were treated with three cannulated compression screws or sliding compression locking plate.
Study NCT06713291 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Three cannulated compression screws
Description: The patients with femoral neck fracture were treated with three cannulated compression screws.
Study NCT05526157 — intervention group
Intervention type: DRUG
Intervention: Glucagon-like peptide-1 receptor agonists (GLP 1 RA)
Description: Retrospective analysis using secondary data collection from various sources
Study NCT05526157 — intervention group
Intervention type: DRUG
Intervention: Steroidal mineral corticoid receptor antagonists (sMRA)
Description: Retrospective analysis using secondary data collection from various sources
Study NCT06713980 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: sham acupuncture
Description: In the sham acupuncture group, sham acupuncture was applied at 14 specific non-acupuncture points on the back.